GLP-1 drugs linked to boosting testosterone, sperm count in men
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GLP-1 drugs linked to boosting testosterone, sperm count in men" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Loma Linda University. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 50d ago.
Quick answers
Why is "GLP-1 drugs linked to boosting testosterone, sperm count in men" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
- Beyond weight loss: How GLP-1 medications are changing men's health Loma Linda University · 90d ago
Topics
Related trends
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Recent studies indicate that popular weight-loss treatments manufactured by Novo Nordisk and Eli Lilly retain efficacy at reduced doses.
Do GLP-1 Drugs Destroy Muscle? The 2026 Meta-Analysis Truth About Ozempic, Protein, and Heavy Lifting
Recent coverage examines the efficacy, safety, and long-term implications of GLP-1 weight-loss medications.
Large genetic study links GLP-1 receptor activation to improved mental well-being
A large genetic study connects GLP-1 receptor activation to improved mental well-being.
Health insurers covered 112,000 fewer Mass. residents’ GLP-1 weight-loss drugs this year, report finds
Health insurers in Massachusetts covered 112,000 fewer residents for GLP-1 weight-loss drugs this year.
Can Obesity Treatment With GLP-1 Drugs Last Forever?
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Will Wegovy Be A Part D, A Medicare GLP-1 Bridge Drug Or Neither?
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.